Evidence map›Paper›PMID 41663462›Full record

ArticleScientific reports2026

Three-dimensional reconstruction of a biliary system in a bioengineered liver using decellularized scaffold.

Hiroshi Horie, Ken Fukumitsu, Yusuke Hanabata, Takuma Karasuyama, Kentaro Iwaki, Fumiaki Munekage, Kenta Makino, Takashi Ito, Katsuhiro Tomofuji, Hidenobu Kojima and 8 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Hiroshi HorieDivision of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogo-in Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Ken FukumitsuDivision of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogo-in Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. tsurugi@kuhp.kyoto-u.ac.jp.
Yusuke HanabataDivision of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogo-in Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Takuma KarasuyamaDivision of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogo-in Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Kentaro IwakiDivision of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogo-in Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Fumiaki MunekageDivision of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogo-in Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Kenta MakinoDivision of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogo-in Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Takashi ItoDivision of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogo-in Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Katsuhiro TomofujiDivision of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogo-in Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Hidenobu KojimaDivision of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogo-in Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Satoshi OgisoDivision of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogo-in Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Elena Yukie UebayashiDivision of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogo-in Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Hiroyuki UematsuDepartment of Clinical Bio-Resource Research and Development, Graduate School of Medicine, Kyoto University, 46-29 Yosida-shimo-adachi-cho, Sakyo-ku, Kyoto, 606- 8501, Japan.
Roberto CoppoDepartment of Clinical Bio-Resource Research and Development, Graduate School of Medicine, Kyoto University, 46-29 Yosida-shimo-adachi-cho, Sakyo-ku, Kyoto, 606- 8501, Japan.
Kunishige OnumaDepartment of Clinical Bio-Resource Research and Development, Graduate School of Medicine, Kyoto University, 46-29 Yosida-shimo-adachi-cho, Sakyo-ku, Kyoto, 606- 8501, Japan.
Masahiro InoueDepartment of Clinical Bio-Resource Research and Development, Graduate School of Medicine, Kyoto University, 46-29 Yosida-shimo-adachi-cho, Sakyo-ku, Kyoto, 606- 8501, Japan.
Takamichi IshiiDivision of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogo-in Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Etsuro HatanoDivision of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, 54 Shogo-in Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioengineered livers are potential alternatives for liver transplantation in patients with end-stage liver disease. Liver scaffolds engineered through decellularization techniques have been developed for clinical applications; however, reconstruction of an integrated biliary system remains a challenge. This study aimed to structurally reconstruct a three-dimensional biliary architecture in bioengineered livers through recellularization of decellularized rat liver scaffolds with rat primary hepatocytes (PHs) and intrahepatic cholangiocyte organoids (ICOs), and to assess bile acid distribution in relation to the reconstructed hepatobiliary architecture. Decellularized rat liver scaffolds were recellularized using rat PHs and green fluorescent protein (GFP)-expressing ICOs. Dissociated ICOs were injected via the bile duct and cultured for 5 days using a perfusion device, followed by PH injection and 2 days of culture. During co-culture, biliary drainage fluid and culture medium were collected to compare total bile acid concentrations using enzyme-linked immunosorbent assay. Histological and immunofluorescence analyses were performed after 7 days of perfusion culture. Histological analyses confirmed the engraftment of GFP-expressing ICOs into bile ducts and PHs into the parenchymal space. Engrafted PHs expressed ZO-1 and MRP2, forming bile canaliculi. In specific regions, MRP2-positive PHs and KRT19-positive ICO-repopulated cells adhered to each other, resembling the native liver structure. In the samples exhibiting such structures, total bile acid concentrations in the biliary drainage fluid tended to be higher than in the culture medium. This study provides evidence supporting the structural reconstruction of a three-dimensional biliary system in bioengineered livers. These findings represent a significant step toward the development of bioengineered livers using decellularization and recellularization techniques.

Indexed as

Biliary TractDecellularized Extracellular MatrixLiverTissue EngineeringTissue ScaffoldsAnimalsBile Acids and SaltsCoculture TechniquesHepatocytesMaleOrganoidsRatsBile Acids and SaltsDecellularized Extracellular MatrixBioartificial organsHepatocytesIntrahepatic cholangiocyte organoidsLiver regenerationTissue engineering

Identifiers

PMID41663462
PMCPMC12960976

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.